ID:SV2A_HUMAN DESCRIPTION: RecName: Full=Synaptic vesicle glycoprotein 2A; FUNCTION: Plays a role in the control of regulated secretion in neural and endocrine cells, enhancing selectively low-frequency neurotransmission. Positively regulates vesicle fusion by maintaining the readily releasable pool of secretory vesicles (By similarity). SUBUNIT: Interacts with SYT1/synaptotagmin-1 in a calcium- dependent manner. Binds the adapter protein complex AP-2 (By similarity). SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane; Multi-pass membrane protein (By similarity). Note=Enriched in chromaffin granules, not present in adrenal microsomes. Associated with both insulin granules and synaptic-like microvesicles in insulin-secreting cells of the pancreas (By similarity). PTM: Phosphorylation by CK1 of the N-terminal cytoplasmic domain regulates interaction with SYT1 (By similarity). PTM: N-glycosylated (By similarity). MISCELLANEOUS: Identified as the brain binding-site for the antiepileptic drug levetiracetam/lev. SIMILARITY: Belongs to the major facilitator superfamily. SEQUENCE CAUTION: Sequence=BAA34456.2; Type=Erroneous initiation; Sequence=CAI12573.1; Type=Erroneous gene model prediction;
The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.
ModBase Predicted Comparative 3D Structure on Q7L0J3
Front
Top
Side
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.
Orthologous Genes in Other Species
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
Biological Process: GO:0006836 neurotransmitter transport GO:0006874 cellular calcium ion homeostasis GO:0007165 signal transduction GO:0007268 chemical synaptic transmission GO:0014052 regulation of gamma-aminobutyric acid secretion GO:0055085 transmembrane transport
BC034038 - Homo sapiens cDNA clone IMAGE:4816121, containing frame-shift errors. AB018279 - Homo sapiens KIAA0736 mRNA for KIAA0736 protein. JD352762 - Sequence 333786 from Patent EP1572962. JD393312 - Sequence 374336 from Patent EP1572962. BC112435 - Homo sapiens cDNA clone IMAGE:40009259. BC114453 - Homo sapiens cDNA clone IMAGE:40009254. JD550767 - Sequence 531791 from Patent EP1572962. JD359613 - Sequence 340637 from Patent EP1572962. JD190521 - Sequence 171545 from Patent EP1572962. JD164419 - Sequence 145443 from Patent EP1572962. BC000776 - Homo sapiens synaptic vesicle glycoprotein 2A, mRNA (cDNA clone IMAGE:3509807), partial cds. BC045111 - Homo sapiens synaptic vesicle glycoprotein 2A, mRNA (cDNA clone MGC:52199 IMAGE:5804662), complete cds. BX537754 - Homo sapiens mRNA; cDNA DKFZp686O1682 (from clone DKFZp686O1682); complete cds. JD055960 - Sequence 36984 from Patent EP1572962. JD205148 - Sequence 186172 from Patent EP1572962. JD266897 - Sequence 247921 from Patent EP1572962. JD422230 - Sequence 403254 from Patent EP1572962. JD260467 - Sequence 241491 from Patent EP1572962. JD419185 - Sequence 400209 from Patent EP1572962. JD132982 - Sequence 114006 from Patent EP1572962. JD254355 - Sequence 235379 from Patent EP1572962. JD065352 - Sequence 46376 from Patent EP1572962. JD038101 - Sequence 19125 from Patent EP1572962. JD068163 - Sequence 49187 from Patent EP1572962. JD214225 - Sequence 195249 from Patent EP1572962. JD483997 - Sequence 465021 from Patent EP1572962. JD472942 - Sequence 453966 from Patent EP1572962. JD126677 - Sequence 107701 from Patent EP1572962. JD226519 - Sequence 207543 from Patent EP1572962. JD547200 - Sequence 528224 from Patent EP1572962. JD171301 - Sequence 152325 from Patent EP1572962. JD148892 - Sequence 129916 from Patent EP1572962. JD254385 - Sequence 235409 from Patent EP1572962. JD068124 - Sequence 49148 from Patent EP1572962. JD042690 - Sequence 23714 from Patent EP1572962. JD126524 - Sequence 107548 from Patent EP1572962. JD178226 - Sequence 159250 from Patent EP1572962. JD501235 - Sequence 482259 from Patent EP1572962. JD399728 - Sequence 380752 from Patent EP1572962. JD055750 - Sequence 36774 from Patent EP1572962. JD049375 - Sequence 30399 from Patent EP1572962. JD207135 - Sequence 188159 from Patent EP1572962. JD304612 - Sequence 285636 from Patent EP1572962. JD161361 - Sequence 142385 from Patent EP1572962. JD548853 - Sequence 529877 from Patent EP1572962. JD372832 - Sequence 353856 from Patent EP1572962. JD260386 - Sequence 241410 from Patent EP1572962. JD155443 - Sequence 136467 from Patent EP1572962. JD502444 - Sequence 483468 from Patent EP1572962. JD218470 - Sequence 199494 from Patent EP1572962. JD419401 - Sequence 400425 from Patent EP1572962. JD250417 - Sequence 231441 from Patent EP1572962. AK303161 - Homo sapiens cDNA FLJ57689 complete cds, highly similar to Synaptic vesicle glycoprotein 2A. JD190832 - Sequence 171856 from Patent EP1572962. JD041601 - Sequence 22625 from Patent EP1572962. AK291718 - Homo sapiens cDNA FLJ75880 complete cds, highly similar to Homo sapiens synaptic vesicle glycoprotein 2A (SV2A), mRNA. JD271087 - Sequence 252111 from Patent EP1572962. JD439752 - Sequence 420776 from Patent EP1572962. JD329417 - Sequence 310441 from Patent EP1572962. EU831489 - Synthetic construct Homo sapiens clone HAIB:100066518; DKFZo008H0717 synaptic vesicle glycoprotein 2A protein (SV2A) gene, encodes complete protein. EU831576 - Synthetic construct Homo sapiens clone HAIB:100066605; DKFZo004H0718 synaptic vesicle glycoprotein 2A protein (SV2A) gene, encodes complete protein. AB383970 - Synthetic construct DNA, clone: pF1KSDA0736, Homo sapiens SV2A gene for synaptic vesicle glycoprotein 2A, complete cds, without stop codon, in Flexi system. AM393578 - Synthetic construct Homo sapiens clone IMAGE:100002311 for hypothetical protein (SV2A gene). AK075480 - Homo sapiens cDNA PSEC0174 fis, clone NT2RP2002760, highly similar to SYNAPTIC VESICLE PROTEIN 2. JD309716 - Sequence 290740 from Patent EP1572962. JD436725 - Sequence 417749 from Patent EP1572962. JD062406 - Sequence 43430 from Patent EP1572962. JD042695 - Sequence 23719 from Patent EP1572962. JD150591 - Sequence 131615 from Patent EP1572962. JD464718 - Sequence 445742 from Patent EP1572962. JD310750 - Sequence 291774 from Patent EP1572962. JD357975 - Sequence 338999 from Patent EP1572962. JD113432 - Sequence 94456 from Patent EP1572962. JD400043 - Sequence 381067 from Patent EP1572962. JD526856 - Sequence 507880 from Patent EP1572962. JD166063 - Sequence 147087 from Patent EP1572962. JD374072 - Sequence 355096 from Patent EP1572962. JD523204 - Sequence 504228 from Patent EP1572962. JD227678 - Sequence 208702 from Patent EP1572962.
Biochemical and Signaling Pathways
Reactome (by CSHL, EBI, and GO)
Protein Q7L0J3 (Reactome details) participates in the following event(s):
R-HSA-5244415 BoNT/A HC:LC binds SV2A, B, or C and GT1b on the target cell surface R-HSA-5250607 BoNT/D HC:LC binds SV2A or B or C and GD2 on the target cell surface R-HSA-5250880 BoNT/F HC:LC binds SV2A or B or C and GT1b on the target cell surface R-HSA-5244503 BoNT/E HC:LC binds SV2A or B and GT1b on the target cell surface R-HSA-5250968 Toxicity of botulinum toxin type A (BoNT/A) R-HSA-5250955 Toxicity of botulinum toxin type D (BoNT/D) R-HSA-5250981 Toxicity of botulinum toxin type F (BoNT/F) R-HSA-5250992 Toxicity of botulinum toxin type E (BoNT/E) R-HSA-168799 Neurotoxicity of clostridium toxins R-HSA-5339562 Uptake and actions of bacterial toxins R-HSA-5663205 Infectious disease R-HSA-1643685 Disease